Scott R. Ward - 07 Feb 2022 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Chairman and CEO, Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Scott R. Ward pursuant to Power of Attorney previously filed.
Issuer symbol: N/A
Transactions as of: 07 Feb 2022
Net transactions value: +$46,293
Form type: 4
Filing time: 09 Feb 2022, 15:15:36 UTC
Previous filing: 31 Aug 2021
Next filing: 23 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSII	Common Stock	Purchase	$46,293	+2,500	+0.44%	$18.52	572,236	07 Feb 2022	Direct	F1
transaction	CSII	Common Stock	Award	$0	+5,477	+0.96%	$0.000000	577,713	08 Feb 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CSII	Restricted Stock Units						34,297	07 Feb 2022	Common Stock	34,297		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.50 to $18.58 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Restrictions lapse as to 2,739 shares on 2/12/23 and as to 2,738 shares on 2/12/24.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of the Company's common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.